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What is known about the subject?
 ► Between 0.1% and 2% of secondary school-aged 
children are affected by chronic fatigue syndrome/
myalgic encephalomyelitis (CFS/ME).
 ► Vigorous exercise can trigger CFS/ME symptoms, 
leading to some patients avoiding physical activity.
 ► Physically active patients with CFS/ME report lower 
levels of fatigue than their inactive counterparts.
What this study adds?
 ► Children and adolescents with chronic fatigue syn-
drome/myalgic encephalomyelitis (CFS/ME) are less 
active than the general child population, but not all 
are inactive. 9.4% of participants met physical activ-
ity recommendations.
 ► Compared with being ‘inactive’, ‘active’ children re-
ported greater physical function but increased anx-
iety, while ‘lightly’ active children reported greater 
physical function and reduced fatigue.
 ► Paediatricians need to recognise that physical activ-
ity varies between patients with CFS/ME when they 
recommend treatment.
AbstrACt
Objective Chronic fatigue syndromemyalgic 
encephalomyelitis (CFS/ME) is relatively common among 
children and adolescents; however, little is known about 
the physical activity levels and patterns of this population. 
The aim of this study was to examine the underlying 
patterns of physical activity among youth with mild-to-
moderate CFS/ME. Cross-sectional associations between 
physical activity patterns with self-reported physical 
function, pain, fatigue, anxiety and depression were also 
examined.
Design Baseline cross-sectional data from the Managed 
Activity Graded Exercise iN Teenagers and pre-Adolescents 
randomised controlled trial.
Patients Children and adolescents (aged 8–17 years) 
diagnosed with mild-to-moderate CFS/ME who wore an 
accelerometer for at least three valid weekdays.
Analyses Latent profile analysis was used to identify 
physical activity patterns. Linear regression models 
examined associations between physical activity classes 
and self-reported physical function, pain, fatigue, anxiety 
and depression.
results 138 children and adolescents (72.5% females) 
had valid data. Overall, participants did less than half the 
government recommended level of physical activity for 
children and adolescents, but not all were inactive: three 
(2.2%) did more than 1 hour of physical activity every 
day, and 13 (9.4%) achieved an average of 60 min a day. 
Adolescents (≥12 years) were less active than younger 
children, but activity levels were similar between genders. 
Three latent classes emerged from the data: ‘active’, ‘light’ 
and ‘inactive’. Compared with being ‘inactive’, being in 
the ‘light’ class was associated with greater self-reported 
physical function (10.35, 95% CI 2.32 to 18.38) and lower 
fatigue (−1.60, 95% CI −3.13 to −0.06), while being 
‘active’ was associated with greater physical function 
(15.26, 95% CI 0.12 to 30.40), but also greater anxiety 
(13.79, 95% CI 1.73 to 25.85).
Conclusions Paediatricians need to be aware 
that physical activity patterns vary widely before 
recommending treatment.
Clinical trial registration ISRCTN registry: 23 962 803
IntrODuCtIOn
Chronic fatigue syndrome or myalgic enceph-
alomyelitis (CFS/ME) is characterised by 
persistent or recurrent debilitating fatigue 
lasting longer than 3 months, with other 
symptoms including malaise, headaches, 
muscle and joint pain, sleep disturbances 
and concentration difficulties.1–3 Anxiety 
and depression are also common among 
patients with CFS/ME.4 The prevalence of 
paediatric CFS/ME is between 0.1% and 
2%.5–8 The UK National Institute for Health 
and Care Excellence (NICE) recommends 
patients with CFS/ME manage their condi-
tion by improving sleep quality, limiting rest 
periods, introducing ‘low level’ physical and 
cognitive activities and eating a well-balanced 
diet.2 Patients with mild-to-moderate CFS/
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ME should also be offered cognitive behavioural therapy, 
graded exercise therapy or activity management.2
CFS/ME symptoms can be triggered by vigorous exer-
cise,9–11 or a sudden increase in physical activity.12 13 
However, little is known about the relationship between 
objectively measured physical activity and the symptoms 
of CFS/ME. The majority of studies that have exam-
ined physical activity among patients with CFS/ME 
have focused on adult populations.9–19 Adult patients 
with CFS/ME are considered to be less physically active 
compared with population data16 18 19 and physically 
inactive adults report greater fatigue.14 15 However, the 
majority of studies used self-reported questionnaires to 
assess physical activity levels, which have low reliability 
and correlation with objective physical activity measure-
ments (eg, accelerometry) in patient and healthy popu-
lations.16 20 21 Patterns of physical activity among adult 
patients with CFS/ME have been classified into two 
subgroups, namely ‘fluctuating active’ and ‘passive’, with 
proportions of 75% versus 25%, respectively.17 ‘Fluctu-
ating active’ or ‘boom-bust’ patients generally show 
infrequent bursts of activity followed by extreme exhaus-
tion, whereas ‘passive’ patients tend not to take part in 
activities.17
Less is known about physical activity levels and patterns 
in paediatric CFS/ME. One study investigated exercise 
capacity in children and adolescents with CFS/ME (N=20, 
mean age 14.9±3.7 years), finding that maximal exercise 
capacity was only reduced in a minority of patients and was 
related to current physical activity levels.22 Another study 
investigated the efficacy of cognitive behavioural therapy 
for adolescent patients with CFS/ME (N=29, mean age 
15.6±1.3 years), with treatment protocols adapted to 
patients’ accelerometer-assessed physical activity patterns 
(‘passive’ vs ‘active’).23 Passive and active patients showed 
equal improvements for fatigue, functional impairment 
and school attendance,23 and rates of improvement were 
larger than seen in previous studies where one protocol 
was used to treat all patients.24 These results suggest that 
adapting treatment to different physical activity patterns 
may improve treatment outcome.23
Children and adolescents with CFS/ME experience 
higher rates of mood disorders than healthy popu-
lations,25–27 with around 30% of adolescent patients 
with CFS/ME experiencing anxiety and/or depres-
sion.26 27 For most children, anxiety and depression 
appear to develop because of their condition.28 29 While 
comorbid mood disorders are associated with increased 
disability, fatigue and pain, there is no evidence on the 
relationship between comorbid mood disorders in CFS/
ME and objectively measured physical activity.
Little is known about physical activity levels and 
patterns in paediatric CFS/ME and how physical activity 
is associated with physical function and other health 
outcomes. Therefore, this study aimed to: (1) determine 
physical activity patterns for children and adolescents 
with mild-to-moderate CFS/ME at treatment commence-
ment and (2) investigate how these activity patterns are 
cross-sectionally associated with physical function, pain, 
fatigue, anxiety and depression.
MethODs
The current analyses used baseline data from the 
Managed Activity Graded Exercise iN Teenagers and 
pre-Adolescents (MAGENTA) study,30 which investigated 
the effectiveness of graded exercise therapy versus activity 
management for treating CFS/ME in patients aged 8–17 
years. Between September 2016 and September 2018, 
data were collected from 237 young people with CFS/
ME in Bath (N=235) and Newcastle (N=2), UK. Written 
parent consent and young person consent/assent was 
received for all participants.
recruitment
Paediatricians and general practitioners referred young 
people with probable CFS/ME to specialist services in 
Bath and Newcastle. The clinician conducting the initial 
assessment in the CFS/ME specialist service identified 
eligible children and adolescents (diagnosed with CFS/
ME based on NICE guidance2 and aged between 8–17 
years). Exclusion criteria included being severely affected 
by CFS/ME, referred for cognitive behavioural therapy at 
first clinical assessment and/or unable to attend clinical 
sessions. NICE defines severe CFS/ME as being unable 
to do activity for themselves, only carrying out minimal 
daily tasks, having severe cognitive difficulties and/or 
depending on a wheelchair for mobility.2
Outcome measures
Data routinely collected at first clinical assessment 
included age, sex, months of illness, Physical Func-
tioning Scale of the 36-Item Short Form Health Survey 
(SF36-PFS),31 pain visual analogue scale, Chalder 
Fatigue scale (CFQ-11),32 Spence Children’s Anxiety 
Scale (SCAS)33 and Hospital Anxiety Depression Scale 
(HADS).34 SF36-PFS comprises 10 items encompassing 
a hierarchical range of difficulties,31 with items scored 
(1–3) based on perceived limitations and higher scores 
indicating greater physical function. Young people were 
asked to indicate pain severity along a continuous line 
from ‘no pain’ to ‘pain as bad as possible’. CFQ-11 meas-
ures the extent and severity of physical and psychological 
fatigue, with items scored on four-point scales ranging 
from ‘less than usual’ to ‘much more than usual’ and 
higher scores indicating greater fatigue.32 SCAS identi-
fies symptoms of anxiety disorders in young people via 
44 items measured on four-point scales ranging from 
‘never’ to ‘always’, with higher scores indicating greater 
anxiety.33 HADS is a 14-item scale measured on individual 
four-point scales assessing agreement with statements 
related to anxiety and depression (eg, ‘I feel tense/
wound up’).34 Due to the sensitive nature of some items, 
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Accelerometer measures
Participants were asked to wear a waist-worn ActiGraph 
GT3X+ accelerometer for seven consecutive days. Accel-
erometer data were processed using Kinesoft (V.3.3.75; 
Kinesoft, Saskatchewan, Canada) in 60 s epochs and were 
included if participants provided at least three valid week-
days. A valid day was defined as at least 500 min (from 
06:00 to 23:00), after excluding intervals of ≥60 min of 
zero counts allowing up to 2 min of interruptions. Mean 
minutes of sedentary, light, moderate-to-vigorous physical 
activity (MVPA) and vigorous-intensity physical activity 
were established using age-appropriate cut-points.35
statistical analysis
Descriptive statistics (means, SDs, t-tests, Wilcoxon) 
were used to describe the sample regarding their phys-
ical activity by age and gender. The t-tests were used to 
examine the differences between boys and girls, while 
Wilcoxon rank-sum tests were used to examine the differ-
ences between two age categories (8–11 years, 12–17 
years), due to the small number of children aged 8–11 
years. All analyses were performed using STATA V.15. 
Latent profile analysis estimates the number of latent 
homogeneous classes in a heterogeneous sample based 
on the pattern of responses on two or more observed 
continuous variables. Three to seven adherent days from 
the participant’s accelerometry was used to determine 
classes of participants who tended to accumulate their 
physical activity or sedentary behaviour in a similar daily 
pattern. Underlying classes were determined based on 
participants who shared similar means for the following 
weighted indicators: proportion of sedentary behaviour 
from total wear time per weekday/weekend day, MVPA 
as a proportion of non-sedentary time per weekday/
weekend day.
To select the appropriate number of classes and maxi-
mise model fit, a series of latent class models (2–6 class 
models) were fit to the data. Beyond this, the sample sizes 
of extreme cases were likely to be too small. To detect 
model identification problems, 100 iterations of each 
model were run using randomly generated seed values. 
Statistical fit indices (Bayesian Information Criterion 
(BIC),36 Akaike Information Criterion (AIC)37) and 
conceptual considerations were used to determine the 
number of classes that adequately described the sample. 
Lower BIC and AIC values were preferred. Additionally, 
theoretical implications and distinctiveness of each latent 
class profile (entropy) were examined, with the aim of 
having high correspondence between established classes 
and some practical interpretation of what the classes 
indicated.
Linear regression models were used to examine whether 
physical activity (using the emergent latent classes) was 
associated with physical function as the primary analysis. 
Secondary analyses examined whether physical activity 
additionally was associated with pain, fatigue, anxiety and 
depression. Models were adjusted for age (years), gender 
and time since diagnosis (months). We adjusted for time 
since diagnosis because we hypothesised that children 
who had been ill for longer would be less fit and engage 
in lower levels of physical activity.
Sensitivity analyses were conducted with participants 
who provided one or 2 days (weekday or weekend) of 
valid accelerometer data, with models rerun and results 
qualitatively compared.
Public and patient involvement
A Patient Advisory Group (PAG) was involved throughout 
the development of the protocol and has remained 
involved throughout the running of the trial, with PAG 
meetings being held every 6 months. Minutes from the 
PAG group will be disseminated to the Study Steering 
Committee and the Trial Management Group. The PAG 
will be consulted for the public dissemination of any 
product arriving from this research.
results
The figure 1 presents the study flow of participants. The 
final sample included 138 participants, of those 16.7% 
were 8–11 years and 83.3% were 12–17 years, while 
27.5% were boys and 72.5% were girls. Median time since 
diagnosis was 14 months (IQR 10–24). Physical activity 
descriptive statistics are presented in table 1. Younger 
children (8–11 years) were less sedentary and engaged 
in more physical activity than adolescents. Three partic-
ipants (2.2%) achieved the UK Government’s physical 
activity recommendations of at least 60 min per day,38 on 
all valid days. Thirteen participants (9.4%) achieved an 
average of 60 min of MVPA per day across the week.
To compare physical activity levels of young people 
with CFS/ME from the present study with children from 
healthy populations, we descriptively examined physical 
activity variables from other UK studies that used the same 
accelerometer cut points.39 40 The Millennium Cohort 
Study was a nationally representative prospective cohort 
study with 6497 children aged 7–8 years.39 B-Proact1v was 
a longitudinal study with 1223 children aged 8–9 years 
from south-west England.40 The table 2 shows the seden-
tary time, MVPA (median, IQR) and proportion meeting 
the recommendations (%, SE). Young people with CFS/
ME in the present study were more sedentary, less active 
and less likely to meet the recommendations than their 
healthy counterparts (9.4% vs, 50.8% Millennium Cohort 
and 46.4% B-Proact1v).
Model fit indices (online supplementary table S1), 
as well as ease of class interpretability and conceptual 
meaning, suggested that the three-class latent class 
model was the most appropriate for the data. The three 
latent classes were classified as: ‘active’, ‘light’ and ‘inac-
tive’. The table 3 presents the latent class prevalence 
and proportion of time spent in each activity category. 
The figure 2 graphically displays the proportion of time 
spent in each activity level on weekdays and weekend days 
for each latent class. The mean number of minutes per 
day of MVPA and sedentary time were ‘active’ 71.63 and 
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Figure 1 Flow chart of participant accelerometer data.








value* Boys (n=38) Girls (n=100) P value†
Sedentary minutes 
per day
555.24 (100.01) 494.48 (75.18) 567.39 (100.18) 0.002 545.61 (110.01) 558.90 (96.28) 0.49
Light minutes per 
day
142.32 (51.32) 176.33 (50.45) 135.52 (49.01) <0.001 143.78 (62.40) 141.77 (46.88) 0.84
Moderate-vigorous 
minutes per day
29.48 (21.98) 39.76 (25.75) 27.42 (20.67) 0.009 30.90 (25.53) 28.94 (20.59) 0.64
Vigorous minutes 
per day
9.72 (12.26) 14.35 (15.61) 8.79 (11.33) 0.008 11.49 (13.12) 9.04 (11.91) 0.30
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Table 2 Comparison between data of patients with chronic fatigue syndrome or myalgic encephalomyelitis and daily physical 
activity data from healthy populations
Median (IQR) unless otherwise stated
Variable
MAGENTA 8–17 years 
(n=138)
Millennium cohort39 7–8 
years (n=6497)
B-Proact1v40 8–9 years 
(n=1026)
Sedentary time (hours) 9.1 (8.2–10.0) 6.4 (5.9–6.9) 7.2 (6.6–7.9)
Moderate-to-vigorous physical 
activity (mins)
25.9 (11.8–39.2) 60.1 (47.1–76.2) 58.21 (45.8–74.8)
Proportion meeting guidelines, % 
(SE)
9.4% (0.025) 50.8% (0.009) 46.4% (0.016)
MAGENTA, Managed Activity Graded Exercise iN Teenagers and pre-Adolescents.
Table 3 Latent class prevalence and proportion of total time spent in each activity
Active Light Inactive
Latent class prevalence 8.7% 44.2% 47.1%
 Proportion of total time spent in each activity
Sedentary time 59.9% 72.9% 82.7%
Light physical activity 29.7% 22.4% 14.9%
Moderate physical activity 5.3% 3.3% 1.7%
Vigorous physical activity 5.0% 1.4% 0.7%
416.28 min, ‘light’ 34.34 and 546.96 min and ‘inactive’ 
17.14 and 588.67 min. The expected proportions of the 
population in each class were 9.0% ‘active’, 43.1% ‘light’ 
and 47.9% ‘inactive’.
The table 4 presents the associations between the emer-
gent physical activity latent classes and young people’s 
self-reported physical function (SF36-PFS). Compared 
with being ‘inactive’, there was evidence that being cate-
gorised as ‘light’ or ‘active’ was associated with a 10.35 
(95% CI 2.32 to 18.38) and 15.26 (95% CI 0.12 to 30.40) 
greater physical function score, respectively.
Online supplementary tables S2-S5 show the associ-
ations between the physical activity latent classes and 
young people’s self-reported pain, fatigue, anxiety and 
depression, respectively. Compared with being ‘inac-
tive’, there was some evidence that being categorised 
as ‘light’ was associated with reduced fatigue, whereby 
young people in this group reported lower levels of 
fatigue (partially adjusted mean difference: −1.60, 95% 
CI −3.13 to −0.06). There was also evidence that being 
in the ‘active’ class was associated with anxiety, whereby 
‘active’ young people reported a 13.79 (95% CI 1.73 to 
25.85) greater anxiety score compared with the ‘inactive’ 
class. There was no evidence for associations between the 
latent classes and pain or depression scores.
sensitivity analysis
When analyses were rerun including participants who 
provided 1–2 days of valid accelerometer data (N=22), 
a four-class model was selected based on the previous 
criteria. The classes were defined as ‘active’, ‘light’, ‘inac-
tive’ and ‘very inactive’. Online supplementary table S6 
shows the latent class prevalence and proportion of total 
time spent in each activity for the sensitivity analysis. 
Online supplementary table S7 presents the associations 
between the emergent latent classes in the sensitivity 
analysis and physical function score. Compared with the 
‘very inactive’ class, there was evidence that being in the 
‘light’ class was associated with a 17.36 (95% CI 0.23 to 
34.48) greater physical function score. Online supple-
mentary tables S8-S11 demonstrate no evidence for asso-
ciations between the physical activity latent classes and 
young people’s pain, fatigue, anxiety and depression, 
respectively.
DIsCussIOn
This is the first study to link patterns of physical activity 
and sedentary behaviour among young people with mild-
to-moderate CFS/ME with differences in fatigue, pain, 
disability, anxiety and depression between the emergent 
latent classes. The three-class model represented mean-
ingful classes that provided more detail than unidimen-
sional measures alone, such as whether children meet 
physical activity recommendations, which may not be 
appropriate for CFS/ME patients.
Compared with a nationally representative sample of 
younger children aged 7–8 years,39 paediatric patients 
with CFS/ME were sedentary for an additional 2.7 hours 
per day and participated in less than half the amount 
of MVPA. However, it is difficult to make comparisons, 
as a multination longitudinal study of children and 
adolescents (aged 2–18 years) from the general popula-
tion, demonstrated that from the age of 5 years there is 
an average cross-sectional decrease of 4.2% in physical 
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Figure 2 Proportion of time spent in activity on weekdays and weekend days.
Table 4 Mean difference in the children’s physical function 
score associated with physical activity latent classes 
(N=137)*
Classes 
Physical function score (unit): mean 
difference (95% CI)




Light 10.91 (2.85 to 18.97) 10.35 (2.32 to 18.38)
Active 16.68 (1.42 to 31.93) 15.26 (0.12 to 30.40)
P for trend 0.01 0.019
*Model 1 is adjusted for age and gender. Model 2 is additionally 
adjusted for time since diagnosis (months).
activity with each additional year.41 This is consistent with 
the findings from the present study, whereby younger chil-
dren aged 8–11 years were more active and less sedentary 
than adolescents. Mean daily MVPA was less than half the 
government’s recommendations for physical activity.38 
Among the general population, boys are less sedentary 
and more active than girls at all ages.41 However, in this 
study, there was no meaningful difference in physical 
activity between genders, most likely due to lower phys-
ical activity levels across the sample.
The ‘active’ class was the smallest of the three classes 
(8.7%), compared with much higher proportions in the 
‘light’ (44.2%) and ‘inactive’ (47.1%) classes. Children 
in the ‘active’ class performed a mean 71.6 min of MVPA 
per day compared with just 17.1 min per day among the 
‘inactive’ class, who were also sedentary for an additional 
3 hours. These results highlight the diversity of physical 
activity behaviour among young people with CFS/ME, 
suggesting treatment protocols should be adapted based 
on physical activity assessment. In a study by Stulemeijer 
and colleagues,23 ‘active’ patients were encouraged to 
reduce their activity, recognise their limitations and 
accept their condition before building up activity levels, 
while ‘passive’ patients were encouraged to address and 
challenge beliefs that activity would aggravate symp-
toms and build up activity as soon as possible. Despite 
receiving different treatments, both groups reported 
decreases in fatigue severity and improvements in school 
attendance,23 and improvement rates were greater than 
studies where only a single protocol was used.24 Previous 
studies with adult patients with CFS/ME identified a ‘fluc-
tuating active’ or ‘boom-bust’ physical activity pattern17; 
however, this pattern did not emerge from the present 
analyses, most likely due to the relatively small sample 
size and missing days of accelerometer data.
Compared with the ‘inactive’ class, being in the ‘light’ or 
‘active’ class was associated with improved physical func-
tion by 10.4 and 15.3 points, respectively, which is greater 
than the minimal clinically importance difference for the 
SF36-PFS.23 42 43 There was some evidence to suggest that 
being in the ‘light’ class was associated with lower levels 
of fatigue compared with being in the ‘inactive’ class, but 
adjusting for time since diagnosis attenuated this associa-
tion. It is possible that engaging in ‘light’ physical activity 
provides some protection against fatigue, but it is also 
possible that the ‘inactive’ group engaged in less activity 
because they were more unwell. This would mean that 
high levels of physical activity could be a marker for less 
severe disease. The present study found that in compar-
ison to the ‘inactive’ class, being classified as ‘active’ was 
not associated with fatigue, which is different to findings 
in adult patients with CFS/ME.15 16 The discrepancy in 
findings with the present study may be due to the differ-
ences in physical activity measurement (self-report vs 
objective) or population (adult vs child) or the very small 
sample size in the ‘active’ class. Being ‘active’ was asso-
ciated with greater anxiety compared with being in the 
‘inactive’ class. It may be that young people are anxious 
because they are physically active or that anxiety is driving 
them to be active. However, the cross-sectional nature of 
the study and the very small sample size of the ‘active’ 
class limit any inferences that can be made. No associ-
ations were present between the physical activity latent 
classes and children’s pain and depression scores.
strengths and limitations
The major strength of this study is the use of latent profile 
analysis to identify patterns of accelerometer-assessed 
physical activity in young people with CFS/ME. While 
cross-sectional analyses are typically viewed as a limita-
tion in observational research, in latent profile analysis, 
the latent variable is assumed to be static or unchanging, 
making the use of cross-sectional data appropriate. 
Limitations include the relatively small sample size, few 
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participants being classified as ‘active’ and missing days of 
accelerometer data that limited the ability to detect other 
physical activity patterns in the data. The SF36-PFS has 
been shown to be reliable and valid for a range of popula-
tions, including older adolescents (aged 14+ years), teen-
agers with CFS/ME, adults, psychiatric patients, patients 
with minor conditions and chronic diseases44 45; however, 
it has not yet been validated with children or younger 
adolescents. The sample was cross-sectional limiting our 
ability to hypothesise about the direction of causality. 
Additionally, the sample was drawn from one region in 
south-west England and limited to patients with mild-to-
moderate CFS/ME, thus patients with severe CFS/ME 
were excluded. As such, our ability to extend findings to 
other populations is limited.
COnClusIOns
This study examined physical activity patterns of young 
people with mild-to-moderate CFS/ME. Although some 
patients with CFS/ME are meeting physical activity guide-
lines, the majority are doing less than half the recom-
mended amount. Compared with being ‘inactive’, there 
was some evidence to suggest being classified as ‘active’ 
was associated with greater physical function but also 
greater anxiety, while being ‘lightly’ active was associated 
with greater physical function and lower levels of fatigue. 
Paediatricians need to recognise that physical activity 
varies between patients with mild-to-moderate CFS/ME 
when they recommend treatment. Future research is 
needed to investigate the relationship between physical 
activity patterns and treatment outcome.
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